Cardiovascular Pharmacotherapeutics

Part 1 Introductory Chapters


1.* Basic Principles

2.* Placebo Effect

3.* Compliance

4.* New Drug Development

5.* Pharmacoeconomics

6.* Cardiovascular Pharm History



Part 2 Drug Classes


7. Alpha & Beta blockers

8. Cholinergic & Anticholinergic Drugs

9. Calcium blockers

10. RAS ?ACE, ARBs

11. Diuretic

12. Mag, K+, Calcium

13. Digitalis and Inotropic Agents

14.* Organic Nitrates and nitroprusside

15.* Central Action, Ganglionic blockers, neuron depletors

16.* Nonspecific antihypertensive vasodilators

17. Antiarrhythmics

18.* Antiplatelets & Antithrombotics

19.* Thrombolytics

20. Lipid lowering/effects of CV drugs on lipoproteins

21.* Combination

22.* Smoking, nicotine

23. Fish oils

24. Antioxidant vitamins and free radical scavengers

25.* Prostacyclin

26. Dopamine



Part 3 New Drugs Classes in Development



27. Natriuretic peptides and neutral endopeptidase

28.* Potassium channel and sodium-hydrogen channel

29.* Serotonin

30.* Imidazoline

31*. Endothelin

32.* Adenosine

33.* Nitric oxide

34.* Renin

35.* Vasopressin

36.* Hormones

37.* Innovative approaches for myocardial ischemia ?focus on
angiogenesis

38.* Angiogenesis

39.* Innovative drug targets

40. Restenosis

41.* Gene therapy

42. Apoptosis

43.* Matrix Metalloproteinase

44. NSAIDS & Cox 2 inhibitors

45. Prostaglandins & P450 Metabolites

46.* Innovative med. approaches to hyperlipidemia